Variant report

Variant	esv3330626
Chromosome Location	chr11:64409926-64412124
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BHLHE40	chr11:64411418-64411584	K562	blood:	n/a	n/a
2	CTBP2	chr11:64411785-64412217	H1-hESC	embryonic stem cell:	n/a	n/a
3	CTBP2	chr11:64410352-64411287	H1-hESC	embryonic stem cell:	n/a	n/a
4	CTCF	chr11:64411084-64411205	MCF-7	breast:	n/a	n/a
5	CTCF	chr11:64411960-64412110	NHEK	skin:	n/a	n/a
6	CTCF	chr11:64411086-64411156	H1-hESC	embryonic stem cell:	n/a	n/a
7	CTCF	chr11:64411107-64411220	MCF-7	breast:	n/a	n/a
8	CTCF	chr11:64411118-64411198	NHEK	skin:	n/a	n/a
9	CTCF	chr11:64411077-64411250	LNCaP	prostate:	n/a	n/a
10	EGR1	chr11:64410858-64411231	H1-hESC	embryonic stem cell:	n/a	chr11:64411107-64411120
11	GATA2	chr11:64411242-64411635	SH-SY5Y	brain:	n/a	n/a
12	GATA2	chr11:64409423-64410072	SH-SY5Y	brain:	n/a	chr11:64409615-64409627 chr11:64409800-64409809
13	MAX	chr11:64411366-64411687	H1-hESC	embryonic stem cell:	n/a	chr11:64411478-64411485 chr11:64411476-64411487 chr11:64411538-64411548 chr11:64411477-64411487
14	MAX	chr11:64411332-64411635	K562	blood:	n/a	chr11:64411478-64411485 chr11:64411476-64411487 chr11:64411538-64411548 chr11:64411477-64411487
15	MAX	chr11:64410952-64411712	H1-hESC	embryonic stem cell:	n/a	chr11:64411478-64411485 chr11:64411476-64411487 chr11:64411538-64411548 chr11:64411265-64411275 chr11:64411107-64411117 chr11:64411477-64411487
16	MAX	chr11:64411335-64411654	MCF-7	breast:	n/a	chr11:64411478-64411485 chr11:64411476-64411487 chr11:64411538-64411548 chr11:64411477-64411487
17	MAX	chr11:64411433-64411594	NB4	blood:	n/a	chr11:64411478-64411485 chr11:64411476-64411487 chr11:64411538-64411548 chr11:64411477-64411487
18	MAX	chr11:64411418-64411523	A549	lung:	n/a	chr11:64411478-64411485 chr11:64411476-64411487 chr11:64411477-64411487
19	MAX	chr11:64411036-64411674	H1-hESC	embryonic stem cell:	n/a	chr11:64411478-64411485 chr11:64411476-64411487 chr11:64411538-64411548 chr11:64411265-64411275 chr11:64411107-64411117 chr11:64411477-64411487
20	MXI1	chr11:64411456-64411656	H1-hESC	embryonic stem cell:	n/a	chr11:64411478-64411487
21	MXI1	chr11:64409351-64411995	SK-N-SH	brain:	n/a	chr11:64411478-64411487
22	MYC	chr11:64411414-64411582	MCF-7	breast:	n/a	chr11:64411478-64411485 chr11:64411476-64411487 chr11:64411538-64411548 chr11:64411477-64411487
23	POLR2A	chr11:64411443-64411628	ProgFib	skin:	n/a	n/a
24	POLR2A	chr11:64411943-64412015	H1-hESC	embryonic stem cell:	n/a	n/a
25	POLR2A	chr11:64411429-64412144	U87	brain:	n/a	n/a
26	POLR2A	chr11:64412020-64412167	H1-hESC	embryonic stem cell:	n/a	n/a
27	POLR2A	chr11:64409300-64412311	H1-neurons	neurons:	n/a	n/a
28	POLR2A	chr11:64410292-64410617	U87	brain:	n/a	n/a
29	POLR2A	chr11:64411268-64411269	H1-hESC	embryonic stem cell:	n/a	n/a
30	POLR2A	chr11:64409535-64411757	H1-neurons	neurons:	n/a	n/a
31	POLR2A	chr11:64411167-64429413	U87	brain:	n/a	n/a
32	POLR2A	chr11:64411378-64412144	U87	brain:	n/a	n/a
33	POLR2A	chr11:64411167-64414430	U87	brain:	n/a	n/a
34	POLR2A	chr11:64410292-64410611	U87	brain:	n/a	n/a
35	REST	chr11:64410280-64411346	H1-neurons	neurons:	n/a	chr11:64410461-64410474
36	SIN3A	chr11:64410939-64411072	H1-hESC	embryonic stem cell:	n/a	n/a
37	SIN3A	chr11:64411872-64412599	H1-hESC	embryonic stem cell:	n/a	chr11:64412399-64412413 chr11:64412383-64412392
38	TCF12	chr11:64410920-64411256	H1-hESC	embryonic stem cell:	n/a	n/a
39	TEAD4	chr11:64410868-64411147	H1-hESC	embryonic stem cell:	n/a	n/a
40	USF1	chr11:64411377-64411588	SK-N-SH_RA	brain:	n/a	n/a
41	USF1	chr11:64411352-64411595	SK-N-SH_RA	brain:	n/a	n/a
42	ZNF143	chr11:64410873-64411209	H1-hESC	embryonic stem cell:	n/a	chr11:64411152-64411162

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr11:64410392-64410442	CMK	blood:	n/a
2	chr11:64411504-64411554	T-47D	breast:	n/a
3	chr11:64409932-64409982	ECC-1	luminal epithelium:	n/a
4	chr11:64410564-64410614	HCF	heart:	n/a
5	chr11:64409932-64409982	NHBE	bronchial:	n/a
6	chr11:64411428-64411478	HEEpiC	esophagus:	n/a
7	chr11:64409932-64409982	PANC-1	pancreas:	n/a
8	chr11:64412085-64412135	Hela-S3	cervix:	n/a
9	chr11:64412079-64412129	MCF-7	breast:	n/a
10	chr11:64410564-64410614	GM12878	blood:	n/a
11	chr11:64412079-64412129	HEEpiC	esophagus:	n/a
12	chr11:64410564-64410614	HNPCEpiC	eye:	n/a
13	chr11:64411504-64411554	GM06990	blood:	n/a
14	chr11:64411428-64411478	AoSMC	blood vessel:	n/a
15	chr11:64411428-64411478	NB4	blood:	n/a
16	chr11:64409932-64409982	AG09309	skin:	n/a
17	chr11:64410564-64410614	AG04450	lung:	fetal
18	chr11:64412079-64412129	HL-60	blood:	n/a
19	chr11:64411428-64411478	SAEC	small airway:	n/a
20	chr11:64411504-64411554	HepG2	liver:	n/a
21	chr11:64412085-64412135	HRCEpiC	kidney:	n/a
22	chr11:64412085-64412135	MCF10A-Er-Src	breast:	n/a
23	chr11:64409932-64409982	HL-60	blood:	n/a
24	chr11:64412079-64412129	HMEC	breast:	n/a
25	chr11:64411504-64411554	ProgFib	skin:	n/a
26	chr11:64412085-64412135	NB4	blood:	n/a
27	chr11:64412085-64412135	HAEpiC	amniotic membrane:	n/a
28	chr11:64412085-64412135	ProgFib	skin:	n/a
29	chr11:64412085-64412135	AG09319	gingival:	n/a
30	chr11:64410392-64410442	U87	brain:	n/a
31	chr11:64412085-64412135	AG09309	skin:	n/a
32	chr11:64411504-64411554	ECC-1	luminal epithelium:	n/a
33	chr11:64411504-64411554	SK-N-SH	brain:	n/a
34	chr11:64410392-64410442	HAEpiC	amniotic membrane:	n/a
35	chr11:64410564-64410614	Caco-2	colon:	n/a
36	chr11:64411504-64411554	BJ	skin:	n/a
37	chr11:64410392-64410442	PrEC	prostate:	n/a
38	chr11:64410564-64410614	T-47D	breast:	n/a
39	chr11:64411504-64411554	MCF-7	breast:	n/a
40	chr11:64410392-64410442	HRPEpiC	eye:	n/a
41	chr11:64410564-64410614	GM12891	blood:	n/a
42	chr11:64409932-64409982	AG10803	skin:	n/a
43	chr11:64412085-64412135	AG04449	skin:	fetal
44	chr11:64409932-64409982	IMR90	lung:	fetal
45	chr11:64410564-64410614	MCF10A-Er-Src	breast:	n/a
46	chr11:64412085-64412135	SK-N-SH	brain:	n/a
47	chr11:64411428-64411478	HUVEC	blood vessel:	n/a
48	chr11:64412079-64412129	SKMC	muscle:	n/a
49	chr11:64411428-64411478	IMR90	lung:	fetal
50	chr11:64412079-64412129	T-47D	breast:	n/a

No.	Distal block	Cell Line	Cell type
1	11:64187725-64189071..11:64402707-64415880	K562	blood:
2	chr11:64406905..64410003-chr11:64415676..64418425,3	K562	blood:
3	chr11:64320459..64321631-chr11:64411779..64413112,6	MCF-7	breast:
4	chr11:64411039..64413414-chr11:64416751..64419165,4	K562	blood:
5	chr11:64411217..64413501-chr11:64452044..64454513,2	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-SLC22A12-2	chr11:64412040-64412054	NONHSAT022001

Variant related genes	Relation type
NRXN2	TF binding region
ENSG00000237410	TF binding region
NRXN2	CpG island
ENSG00000237410	CpG island
ENSG00000231492	chromatin interactions

Extended variants
information (count: 67 )
Associated
traits (count: 97 )

Variant overlapped rSNPs/rCNVs (count:67 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs371486797	chr11:64410005-64410006	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs533170963	chr11:64410007-64410008	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs373885284	chr11:64410048-64410049	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs200324728	chr11:64410066-64410067	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs138224166	chr11:64410075-64410076	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs529571302	chr11:64410110-64410111	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs549289478	chr11:64410132-64410133	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs569067675	chr11:64410141-64410142	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs373007284	chr11:64410150-64410151	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs377111588	chr11:64410169-64410170	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
11	rs4373928	chr11:64410196-64410197	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
12	rs557563727	chr11:64410223-64410224	Bivalent/Poised TSS Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
13	rs575121691	chr11:64410349-64410350	Bivalent/Poised TSS Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
14	rs571359241	chr11:64410384-64410385	Bivalent/Poised TSS Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
15	rs533537366	chr11:64410425-64410426	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers Flanking Active TSS	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
16	rs191726328	chr11:64410454-64410455	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
17	rs541647050	chr11:64410497-64410498	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
18	rs573699029	chr11:64410564-64410565	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers Flanking Active TSS	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
19	rs542906748	chr11:64410651-64410652	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
20	rs556509935	chr11:64410737-64410738	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
21	rs35182709	chr11:64410743-64410744	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
22	rs534827428	chr11:64410835-64410836	Bivalent/Poised TSS Active TSS Weak transcription Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
23	rs576112274	chr11:64410837-64410838	Bivalent/Poised TSS Active TSS Weak transcription Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
24	rs545237883	chr11:64410838-64410839	Bivalent/Poised TSS Active TSS Weak transcription Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
25	rs398048294	chr11:64410842-64410843	Bivalent/Poised TSS Active TSS Weak transcription Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
26	rs12575581	chr11:64410877-64410878	Bivalent/Poised TSS Active TSS Weak transcription Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
27	rs564417250	chr11:64410891-64410892	Bivalent/Poised TSS Active TSS Weak transcription Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
28	rs145408157	chr11:64410936-64410937	Bivalent/Poised TSS Active TSS Weak transcription Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
29	rs183471641	chr11:64410937-64410938	Bivalent/Poised TSS Active TSS Weak transcription Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
30	rs533502912	chr11:64410948-64410949	Bivalent/Poised TSS Active TSS Weak transcription Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
31	rs71579882	chr11:64410978-64410979	Bivalent/Poised TSS Active TSS Weak transcription Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
32	rs560087194	chr11:64410994-64410995	Bivalent/Poised TSS Active TSS Weak transcription Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
33	rs529265648	chr11:64410999-64411000	Bivalent/Poised TSS Active TSS Weak transcription Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
34	rs375986449	chr11:64411021-64411022	Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
35	rs549218087	chr11:64411028-64411029	Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
36	rs71579880	chr11:64411093-64411094	Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
37	rs563805958	chr11:64411146-64411147	Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
38	rs569580587	chr11:64411182-64411183	Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
39	rs531801289	chr11:64411237-64411238	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
40	rs111814765	chr11:64411246-64411247	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
41	rs551983786	chr11:64411260-64411261	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
42	rs571230904	chr11:64411264-64411265	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
43	rs560263198	chr11:64411269-64411270	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
44	rs547528083	chr11:64411299-64411300	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
45	rs111657360	chr11:64411359-64411360	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
46	rs71579879	chr11:64411367-64411368	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs369412874	chr11:64411421-64411422	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers Genic enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
48	rs536260024	chr11:64411463-64411464	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers Genic enhancers	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
49	rs113277513	chr11:64411496-64411497	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers Genic enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
50	rs556497726	chr11:64411552-64411553	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers Genic enhancers	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:97)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Gastric cancer	17908304	CNVD
Multiple myeloma	20724749	CNVD
Wilms tumour	21544195	CNVD
Autism	22495311	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Non-small cell lung cancer	21385341	CNVD
Intellectual disability	22102821	CNVD
Glioblastoma multiforme	21138945	CNVD
Acute myeloid leukemia	20729466	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	21637783	CNVD
Acute myeloid leukemia	16864856	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	21484798	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	21386901	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Cervical cancer	21063398	CNVD
Glioblastoma multiforme	19960244	CNVD
Liposarcoma	21253554	CNVD
Neuroblastoma	18923524	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Neuroblastoma	17533364	CNVD
Breast cancer	21364760	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Pituitary adenoma	18645599	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Prostate cancer	18632612	CNVD
Glioblastoma multiforme	21080181	CNVD
Smith-Lemli-Opitz syndrome	21572526	CNVD
Multiple myeloma	16461302	CNVD
Cancer	16751803	CNVD
Seminomas	18059402	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Metanephric adenoma	20802469	CNVD
Chordoma	21602918	CNVD
Melanoma	18172304	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
ovarian endometriomas	16273235	CNVD
Breast cancer	16417655	CNVD
Myelofibrosis	22110671	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Prostate cancer	17217626	CNVD
T-cell acute lymphoblastic leukemia	19406988	CNVD
Breast cancer	21045282	CNVD
Breast cancer	21806811	CNVD
Breast cancer	22002566	CNVD
Ductal carcinoma	18381933	CNVD
Retinoblastoma	22278416	CNVD
Breast cancer	20953835	CNVD
oto-dental syndrome	17656375	CNVD
Asthma	21956041	CNVD
Breast cancer	17603634	CNVD
Ovarian neoplasms	16753589	CNVD
Non-small cell lung cancer	20864512	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	21509527	CNVD
Anaplastic thyroid cancer	18753363	CNVD
Prostate cancer	18779856	CNVD
Cancer	17160897	CNVD
Breast cancer	17001317	CNVD
Oral squamous cell carcinoma	16619035	CNVD
Intracranial aneurysm	16715129	CNVD
Colorectal cancer	16272173	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Colorectal cancer	16882699	CNVD
Berardinelli-seip congenital generalized lipodystrophy	17668395	CNVD
Spinal muscular atrophy	17668395	CNVD
Neonatal seizures	17668395	CNVD
Neonatal seizures	17668391	CNVD
Neuroticism	17667963	CNVD
Cancer	17916600	CNVD
Squamous cell cancer	19047905	CNVD
Multiple endocrine neoplasia type 1	19566914	CNVD
XY sex reversal	17503084	CNVD
Berardinelli-seip congenital generalized lipodystrophy	17668391	CNVD
Maculopathy	17646752	CNVD
Breast cancer	17899364	CNVD
Breast cancer	17157792	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Hodgkin''s lymphoma	17606441	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Cancer	20164919	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:269 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:64403000-64410400	Weak transcription	Aorta	Aorta
2	chr11:64406600-64410800	Active TSS	Brain Angular Gyrus	brain
3	chr11:64406800-64411400	Active TSS	Brain Anterior Caudate	brain
4	chr11:64408400-64410000	Flanking Active TSS	Fetal Brain Male	brain
5	chr11:64408800-64411400	Weak transcription	Gastric	stomach
6	chr11:64409200-64410000	Flanking Bivalent TSS/Enh	Fetal Stomach	stomach
7	chr11:64409200-64410400	Bivalent Enhancer	Fetal Thymus	thymus
8	chr11:64409200-64410600	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
9	chr11:64409200-64411000	Bivalent/Poised TSS	Fetal Intestine Small	intestine
10	chr11:64409200-64411400	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
11	chr11:64409200-64411400	Bivalent/Poised TSS	Fetal Muscle Trunk	muscle
12	chr11:64409200-64411600	Bivalent/Poised TSS	Duodenum Smooth Muscle	Duodenum
13	chr11:64409400-64410000	Bivalent Enhancer	Primary T helper naive cells fromperipheralblood	blood
14	chr11:64409400-64410000	Bivalent Enhancer	Primary T killer naive cells fromperipheralblood	blood
15	chr11:64409400-64410000	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
16	chr11:64409400-64410000	Flanking Active TSS	Brain Germinal Matrix	brain
17	chr11:64409400-64410000	Bivalent/Poised TSS	Brain Hippocampus Middle	brain
18	chr11:64409400-64410000	Flanking Bivalent TSS/Enh	Fetal Lung	lung
19	chr11:64409400-64410400	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
20	chr11:64409400-64410400	Flanking Bivalent TSS/Enh	Cortex derived primary cultured neurospheres	brain
21	chr11:64409400-64410400	Bivalent/Poised TSS	Fetal Intestine Large	intestine
22	chr11:64409400-64410400	Enhancers	Spleen	Spleen
23	chr11:64409400-64410600	Bivalent Enhancer	Primary T helper naive cells from peripheral blood	blood
24	chr11:64409400-64410800	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
25	chr11:64409400-64411000	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
26	chr11:64409400-64411200	Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
27	chr11:64409400-64411400	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
28	chr11:64409400-64411400	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
29	chr11:64409400-64411400	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
30	chr11:64409400-64411600	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
31	chr11:64409600-64410000	Flanking Bivalent TSS/Enh	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
32	chr11:64409600-64410000	Bivalent Enhancer	Primary T cells from cord blood	blood
33	chr11:64409600-64410000	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
34	chr11:64409600-64410000	Flanking Bivalent TSS/Enh	Ganglion Eminence derived primary cultured neurospheres	brain
35	chr11:64409600-64410200	Flanking Bivalent TSS/Enh	iPS DF 19.11 Cell Line	embryonic stem cell
36	chr11:64409600-64410200	Bivalent/Poised TSS	Rectal Smooth Muscle	rectum
37	chr11:64409600-64410600	Bivalent Enhancer	Primary hematopoietic stem cells	blood
38	chr11:64409600-64410600	Enhancers	Pancreas	Pancrea
39	chr11:64409600-64410800	Bivalent Enhancer	Primary B cells from peripheral blood	blood
40	chr11:64409600-64410800	Bivalent/Poised TSS	Fetal Adrenal Gland	Adrenal Gland
41	chr11:64409600-64411400	Bivalent/Poised TSS	H1 Cell Line	embryonic stem cell
42	chr11:64409600-64411400	Bivalent/Poised TSS	H9 Derived Neuron Cultured Cells	ES cell derived
43	chr11:64409600-64411400	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
44	chr11:64409600-64411400	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
45	chr11:64409600-64411400	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
46	chr11:64409600-64411600	Active TSS	Fetal Brain Female	brain
47	chr11:64409800-64410000	Bivalent Enhancer	Primary T helper memory cells from peripheral blood 2	blood
48	chr11:64409800-64410000	Flanking Active TSS	Brain Inferior Temporal Lobe	brain
49	chr11:64409800-64410000	Bivalent/Poised TSS	Colon Smooth Muscle	Colon
50	chr11:64409800-64410000	Flanking Active TSS	Ovary	ovary

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links